Chronic inflammatory demyelinating polyneuropathy: Clinical subtypes and their correlation with electrophysiology

Clinical and Experimental Neuroimmunology

Volumn 2, Issue 2, 2011, Pages 41-48

  Kuwabara, Satoshi ^a   Misawa, Sonoko ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

blood nerve barrier; chronic inflammatory demyelinating polyneuropathy; demyelination; nerve conduction

Indexed keywords

BLOOD NERVE BARRIER; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONTRAST ENHANCEMENT; DEMYELINATING NEUROPATHY; ELECTROPHYSIOLOGY; GUILLAIN BARRE SYNDROME; HUMAN; MOTOR DYSFUNCTION; MULTIFOCAL ACQUIRED DEMYELINATING SENSORY AND MOTOR NEUROPATHY; MUSCLE WEAKNESS; NERVE BLOCK; NERVE ENDING; NERVE ROOT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POEMS SYNDROME; PRIORITY JOURNAL; REVIEW; SENSORIMOTOR NEUROPATHY;

EID: 80051692523     PISSN: None     EISSN: 17591961     Source Type: Journal    
DOI: 10.1111/j.1759-1961.2011.00020.x     Document Type: Review

References (38)

1. Ad Hoc Subcommittee for the American Academy of Neurology AIDS Task Force. Research criteria for chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology. 1991; 41: 617-8.
2. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki M, Groover RV,. Chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clin Proc. 1975; 50: 621-37.
3. McCombe PA, Pollard JD, Mcleod JG,. Chronic inflammatory demyelinating polyradiculoneuropathy. Brain. 1987; 110: 1617-30.
4. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR,. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol. 1989; 46: 878-84. (Pubitemid 19199372)
5. Simmons Z, Albers JW, Bromberg MB, Feldman EL,. Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology. 1993; 43: 2202-9. (Pubitemid 23346948)
6. Sghirlanzoni A, Solari A, Ciano C, Mariotti C, Fallica E, Pareyson D,. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients. Neurol Sci. 2000; 21: 31-7. (Pubitemid 30430856)
7. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Jackson CE, et al., Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve. 1999; 22: 560-6. (Pubitemid 29214420)
8. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst. 2005; 10: 220-8 and Eur J Neurol. 2005; 13: 326-32.
9. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst. 2010; 15: 1-9.
10. Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T,. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2002; 72: 37-42. (Pubitemid 34073093)
11. Olsson Y,. Microenviroment of the peripheral nervous system under normal and pathological conditions. Crit Rev Neurobiol. 1990; 5: 265-311. (Pubitemid 20128523)
12. Bromberg MB, Albers JW,. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders. Muscle Nerve. 1993; 16: 262-6. (Pubitemid 23067736)
13. Kuwabara S,. The blood-nerve barrier and sensory nerve conduction. Clin Neurophysiol. 2007; 118: 1901-2. (Pubitemid 47189742)
14. Thaisetthawatkul P, Logigian EL, Hermann DN,. Dispersion of distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology. 2002; 59: 1526-32. (Pubitemid 35387056)
15. Isose S, Kuwabara S, Kokubun N, Sato Y, Mori M, Shibuya K, et al., Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. J Peripher Nerv Syst. 2009; 14: 151-8.
16. Hara M, Kimura J, Walker DD, Taniguchi S, Ichikawa H, Fujisawa R, et al., Effect of motor imagery and voluntary muscle contraction on the F wave. Muscle Nerve. 2010; 42: 208-12.
17. Stanton M, Pannoni V, Lewis RA, Logigian EL, Naguib D, Shy ME, et al., Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2006; 34: 417-22. (Pubitemid 44506708)
18. Taniguchi S, Kimura J, Yamada T, Ichikawa H, Hara M, Fujisawa R, et al., Effect of motion imagery to counter rest-induced suppression of F-wave as a measure of anterior horn cell excitability. Clin Neurophysiol. 2008; 119: 1346-52.
19. Duggins AJ, McLeod JG, Pollard JD, Davies L, Yang F, Thompson EO, et al., Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain. 1999; 122: 1383-90. (Pubitemid 29324858)
20. Pytel P, Rezania K, Soliven B, Frank J, Wollmann R,. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with hypertrophic spinal radiculopathy mimicking neurofibromatosis. Acta Neuropathol. 2003; 105: 185-8. (Pubitemid 36798805)
21. Tazawa K, Matsuda M, Yoshida T, Shimojima Y, Gono T, Morita H, et al., Spinal nerve root hypertrophy on MRI: clinical significance in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. Intern Med. 2008; 47: 2019-24.
22. Kuwabara S, Nakajima M, Matsuda S, Hattori T,. Magnetic resonance imaging at the demyelinative foci in chronic inflammatory demyelinating polyneuropathy. Neurology. 1997; 48: 874-7.
23. Matsuda M, Ikeda S, Sakurai S, et al., Hypertrophic neuritis due to chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a postmortem pathological study. Muscle Nerve. 1996; 19: 163-9. (Pubitemid 26038077)
24. Yuki N, Odaka M,. Ganglioside mimicry as a cause of Guillain-Barré syndrome. Curr Opin Neurol. 2005; 18: 557-61. (Pubitemid 41476143)
25. Yuki N, Kuwabara S,. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology. J Peripher Nerv Syst. 2007; 12: 238-49. (Pubitemid 350179489)
26. Bostock H, Burke D, Hales JP,. Differences in behaviour of sensory and motor axons following release of ischaemia. Brain. 1994; 117: 225-34. (Pubitemid 24155495)
27. Bostock H, Rothwell JC,. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol. 1997; 498: 277-94. (Pubitemid 27056895)
28. Kuwabara S, Misawa S,. Axonal ionic pathophysiology in human peripheral neuropathy and motor neuron disease. Curr Neurovasc Res. 2004; 1: 373-9.
29. Tasaki I,. Nature of the local excitatory state in the nerve fiber. Jpn J Physiol. 1950; 126: 367-79.
30. Kiernan MC, Guglielmi JM, Kaji R, Murray NM, Bostock H,. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain. 2002; 125: 664-75. (Pubitemid 34194419)
31. Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ,. Distal acquired demyelinating symmetric neuropathy. Neurology. 2000; 54: 615-20. (Pubitemid 30082927)
32. Kaku DA, England JD, Sumner AJ,. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain. 1994; 117: 941-7. (Pubitemid 24350530)
33. Dalakas MC,. Pathogenesis and Treatment of Anti-MAG Neuropathy. Curr Treat Options Neurol. 2010; 12: 71-83.
34. Sinnreich M, Klein CJ, Daube JR, Engelstad J, Spinner RJ, Dyck PJ,. Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology. 2004; 63: 1662-9. (Pubitemid 39507585)
35. Kuwabara S, Dispenzieri A, Arimura K, Misawa S,. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane Database Syst Rev. 2008; 4: CD006828.
36. Sung JY, Kuwabara S, Ogawara K, Kanai K, Hattori T,. Patterns of nerve conduction abnormalities in POEMS syndrome. Muscle Nerve. 2002; 26: 189-93. (Pubitemid 34832800)
37. Iijima M, Yamamoto M, Hirayama M, et al., Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP. Neurology. 2005; 64: 1471-5. (Pubitemid 40570528)
38. Iijima M, Tomita M, Morozumi S, et al., Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP. Neurology. 2009; 73: 1348-52.